2395 — Shin Nippon Biomedical Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00
- ¥59bn
- ¥73bn
- ¥25bn
- 68
- 58
- 31
- 52
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1,651 | 3,063 | 4,176 | 8,183 | 7,760 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -725 | -381 | -1,512 | -3,805 | -2,574 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 605 | -892 | 896 | 397 | -2,784 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 2,893 | 3,018 | 4,747 | 5,953 | 4,002 |
Capital Expenditures | -1,100 | -1,230 | -1,118 | -1,614 | -4,956 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 1,535 | -225 | 849 | -2,654 | -975 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 435 | -1,455 | -269 | -4,269 | -5,931 |
Financing Cash Flow Items | -0.001 | -70.8 | -6.6 | -2.95 | 33.9 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3,502 | -1,450 | -2,471 | -4,912 | 6,266 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -159 | 109 | 2,037 | -2,731 | 4,649 |